Your browser doesn't support javascript.
loading
Changes in immune cell populations following KappaMab, lenalidomide and low-dose dexamethasone treatment in multiple myeloma.
Norton, Samuel E; Khong, Tiffany; Ramachandran, Malarmathy; Highton, Andrew J; Ward-Hartstonge, Kirsten A; Shortt, Jake; Spencer, Andrew; Kemp, Roslyn A.
Afiliación
  • Norton SE; Nanix Limited Dunedin New Zealand.
  • Khong T; Myeloma Research Group, Australian Centre for Blood Diseases Alfred Hospital-Monash University Melbourne VIC Australia.
  • Ramachandran M; Department of Clinical Haematology and Stem Cell Transplantation Alfred Hospital Melbourne VIC Australia.
  • Highton AJ; Myeloma Research Group, Australian Centre for Blood Diseases Alfred Hospital-Monash University Melbourne VIC Australia.
  • Ward-Hartstonge KA; Department of Microbiology and Immunology University of Otago Dunedin New Zealand.
  • Shortt J; Department of Microbiology and Immunology University of Otago Dunedin New Zealand.
  • Spencer A; Monash Haematology Monash Health Clayton VIC Australia.
  • Kemp RA; Blood Cancer Therapeutics Laboratory, Department of Medicine School of Clinical Sciences at Monash Health Clayton VIC Australia.
Clin Transl Immunology ; 12(12): e1478, 2023.
Article en En | MEDLINE | ID: mdl-38034081
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Clin Transl Immunology Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Clin Transl Immunology Año: 2023 Tipo del documento: Article